The Australian sharemarket finished stronger on Thursday after US stock indexes recovered from big early drops to finish higher, led by a small group...
Vous n'êtes pas connecté
Acrux’s stock jumped after the US FDA approved its acne gel. Island Pharma has begun patient screening for Phase 2 ...
The Australian sharemarket finished stronger on Thursday after US stock indexes recovered from big early drops to finish higher, led by a small group...
FDA approves J&J's Tremfya for ulcerative colitis. NVO's oral obesity pill, amycretin, shows faster weight loss than weekly injection, Wegovy.
The domestic sharemarket was stronger on Thursday after most US stocks fell overnight, as traders reduced their expectations for Federal Reserve...
The domestic sharemarket was stronger on Thursday after most US stocks fell overnight, as traders reduced their expectations for Federal Reserve...
The Australian sharemarket is set to open little changed this morning after US stocks lost more ground ahead of a key jobs report on Friday.
The Australian sharemarket is set to open little changed this morning after US stocks lost more ground ahead of a key jobs report on Friday.
The Australian sharemarket is set to open little changed this morning after US stocks lost more ground ahead of a key jobs report on Friday.
The Australian sharemarket is set to open little changed this morning after US stocks lost more ground ahead of a key jobs report on Friday.
The FDA removes the partial clinical holds on Rezolute's phase III study evaluating RZ358 for treating congenital hyperinsulinism.
The FDA removes the partial clinical holds on Rezolute's phase III study evaluating RZ358 for treating congenital hyperinsulinism.